Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
1 other identifier
interventional
98
1 country
1
Brief Summary
Epilepsy is a common health problem worldwide. In general population, studies in developed countries estimated the annual incidence of epilepsy to be\~50 per 100,000 and prevalence to be \~8.2 per 1,000. These figures are higher in developing countries in which prevalence of \>10 per 1,000 was reported. In Upper Egypt, Assiut Governorate, the prevalence rate was 12.9 per 1,000. In people with epilepsy there is an associated high rate of cognitive difficulties that compromise educational progress and achievement throughout life. Approximately 1-5% of the population exhibits epileptiform discharges on electroencephalography (EEG). Interictal epileptiform discharges (IEDs), meaning spikes, polyspikes, sharp waves, or spike and slow-wave complexes without observed clinical seizures, are commonly observed in patients with epilepsy. Epilepsy syndromes manifesting with IEDs are detrimental to cognitive function. Recently, two studies found that frequent IEDs can impair cognitive performance in children. and adult patients. Several studies indicated that IEDs in patients with epilepsy had a disruptive effect on information processing speed with even a low percentage of IEDs (1%).However, it is unclear whether IEDs are associated with disrupted academic performance in patients with idiopathic epilepsy, and the relationship between general cognitive ability and academic performance in those patients has not been clarified. Understanding how IEDs interfere with neurocognitive outcomes is important ,while the goal of medical and surgical treatments for epilepsy is to achieve seizure-freedom with minimal morbidity, the benefits of IED suppression are more controversial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2021
CompletedStudy Start
First participant enrolled
September 30, 2021
CompletedFirst Posted
Study publicly available on registry
October 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedOctober 5, 2021
October 1, 2021
7 months
September 20, 2021
October 2, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluate the effect of some High frequency epileptiform discharges measured by HZ on some cognitive domines using electroencephalogram
2 months
Study Arms (2)
Epilepsy
OTHERNewly diagnosed epileptic patients
Control
SHAM COMPARATORhealthy subjects
Interventions
Digital electroencephalography (EEG) for an hour (16 channels)
Eligibility Criteria
You may qualify if:
- \- a) Patients \[with age ranges from 10 to 50 years\] of both sex. b) Patients with confirmed diagnosis of idiopathic localization-related or generalized epilepsy.
- c) Either before receiving anti-epileptic drugs or on regular treatment with antiepileptic drugs for less three months.
You may not qualify if:
- Patients with symptomatic or secondary epilepsies either due to general medical conditions or drug induced.
- Other neurological , psychiatric or metabolic disorders that affect cognition.
- Regular use of antiepileptic medications more than three months.
- utilization of regular medications other than AEDs that affect cognition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shady Mohamed Safwat Mohamed Tawfik Hassan
Asyut, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Neurology
Study Record Dates
First Submitted
September 20, 2021
First Posted
October 5, 2021
Study Start
September 30, 2021
Primary Completion
May 1, 2022
Study Completion
June 1, 2022
Last Updated
October 5, 2021
Record last verified: 2021-10